ESR1 and breast carcinoma: Since researchers discovered that 27OHC was a selective endogenous modulator of ER-α, a number of studies have shown that the activation of ER-α by 27OHC in breast cancer cells culminates in increased cell proliferation and consequently promotes ER-α-positive breast cancer progression [13].